Stattic: a small-molecule inhibitor of STAT3 activation and dimerization - PubMed (original) (raw)
Stattic: a small-molecule inhibitor of STAT3 activation and dimerization
Jochen Schust et al. Chem Biol. 2006 Nov.
Abstract
Signal transducers and activators of transcription (STATs) are a family of latent cytoplasmic transcription factors that transmit signals from the cell membrane to the nucleus. One family member, STAT3, is constitutively activated by aberrant upstream tyrosine kinase activities in a broad spectrum of cancer cell lines and human tumors. Screening of chemical libraries led to the identification of Stattic, a nonpeptidic small molecule shown to selectively inhibit the function of the STAT3 SH2 domain regardless of the STAT3 activation state in vitro. Stattic selectively inhibits activation, dimerization, and nuclear translocation of STAT3 and increases the apoptotic rate of STAT3-dependent breast cancer cell lines. We propose Stattic as a tool for the inhibition of STAT3 in cell lines or animal tumor models displaying constitutive STAT3 activation.
Comment in
- A new small-molecule Stat3 inhibitor.
McMurray JS. McMurray JS. Chem Biol. 2006 Nov;13(11):1123-4. doi: 10.1016/j.chembiol.2006.11.001. Chem Biol. 2006. PMID: 17113993 - Revisiting the specificity of small molecule inhibitors: the example of stattic in dendritic cells.
Sanseverino I, Purificato C, Gauzzi MC, Gessani S. Sanseverino I, et al. Chem Biol. 2012 Oct 26;19(10):1213-4; author reply 1215-6. doi: 10.1016/j.chembiol.2012.08.021. Chem Biol. 2012. PMID: 23102212 No abstract available.
Similar articles
- A new small-molecule Stat3 inhibitor.
McMurray JS. McMurray JS. Chem Biol. 2006 Nov;13(11):1123-4. doi: 10.1016/j.chembiol.2006.11.001. Chem Biol. 2006. PMID: 17113993 - In silico simulations of STAT1 and STAT3 inhibitors predict SH2 domain cross-binding specificity.
Szelag M, Sikorski K, Czerwoniec A, Szatkowska K, Wesoly J, Bluyssen HA. Szelag M, et al. Eur J Pharmacol. 2013 Nov 15;720(1-3):38-48. doi: 10.1016/j.ejphar.2013.10.055. Epub 2013 Nov 6. Eur J Pharmacol. 2013. PMID: 24211327 - XZH-5 inhibits STAT3 phosphorylation and causes apoptosis in human hepatocellular carcinoma cells.
Liu Y, Liu A, Xu Z, Yu W, Wang H, Li C, Lin J. Liu Y, et al. Apoptosis. 2011 May;16(5):502-10. doi: 10.1007/s10495-011-0578-0. Apoptosis. 2011. PMID: 21311975 - STAT 3 as a target for cancer drug discovery.
Costantino L, Barlocco D. Costantino L, et al. Curr Med Chem. 2008;15(9):834-43. doi: 10.2174/092986708783955464. Curr Med Chem. 2008. PMID: 18473793 Review. - Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors.
Siveen KS, Sikka S, Surana R, Dai X, Zhang J, Kumar AP, Tan BK, Sethi G, Bishayee A. Siveen KS, et al. Biochim Biophys Acta. 2014 Apr;1845(2):136-54. doi: 10.1016/j.bbcan.2013.12.005. Epub 2014 Jan 2. Biochim Biophys Acta. 2014. PMID: 24388873 Review.
Cited by
- PKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning STAT3 activation.
Damasceno LEA, Prado DS, Veras FP, Fonseca MM, Toller-Kawahisa JE, Rosa MH, Públio GA, Martins TV, Ramalho FS, Waisman A, Cunha FQ, Cunha TM, Alves-Filho JC. Damasceno LEA, et al. J Exp Med. 2020 Oct 5;217(10):e20190613. doi: 10.1084/jem.20190613. J Exp Med. 2020. PMID: 32697823 Free PMC article. - Critical role of STAT3 in IL-6-mediated drug resistance in human neuroblastoma.
Ara T, Nakata R, Sheard MA, Shimada H, Buettner R, Groshen SG, Ji L, Yu H, Jove R, Seeger RC, DeClerck YA. Ara T, et al. Cancer Res. 2013 Jul 1;73(13):3852-64. doi: 10.1158/0008-5472.CAN-12-2353. Epub 2013 Apr 30. Cancer Res. 2013. PMID: 23633489 Free PMC article. - Oligonucleotide-Based Therapeutics for STAT3 Targeting in Cancer-Drug Carriers Matter.
Molenda S, Sikorska A, Florczak A, Lorenc P, Dams-Kozlowska H. Molenda S, et al. Cancers (Basel). 2023 Nov 29;15(23):5647. doi: 10.3390/cancers15235647. Cancers (Basel). 2023. PMID: 38067351 Free PMC article. Review. - A novel inhibitor of STAT3 homodimerization selectively suppresses STAT3 activity and malignant transformation.
Zhang X, Sun Y, Pireddu R, Yang H, Urlam MK, Lawrence HR, Guida WC, Lawrence NJ, Sebti SM. Zhang X, et al. Cancer Res. 2013 Mar 15;73(6):1922-33. doi: 10.1158/0008-5472.CAN-12-3175. Epub 2013 Jan 15. Cancer Res. 2013. PMID: 23322008 Free PMC article. - miR-181b functions as an oncomiR in colorectal cancer by targeting PDCD4.
Liu Y, Uzair-Ur-Rehman, Guo Y, Liang H, Cheng R, Yang F, Hong Y, Zhao C, Liu M, Yu M, Zhou X, Yin K, Chen J, Zhang J, Zhang CY, Zhi F, Chen X. Liu Y, et al. Protein Cell. 2016 Oct;7(10):722-734. doi: 10.1007/s13238-016-0313-2. Epub 2016 Sep 19. Protein Cell. 2016. PMID: 27647131 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous